CTKB icon

Cytek Biosciences

52 hedge funds and large institutions have $572M invested in Cytek Biosciences in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-2
Holders Change %
-3.7%
% of All Funds
0.8%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
20
Reduced
9
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$170 +$170 +10,392 New
DCM
52
Driehaus Capital Management
Illinois
-$9.45M -441,518 Closed
SAM
53
Sectoral Asset Management
Quebec, Canada
-$7.02M -328,080 Closed
Millennium Management
54
Millennium Management
New York
-$3.83M -178,978 Closed
CCM
55
CAAS Capital Management
New York
-$2.14M -100,000 Closed
Ameriprise
56
Ameriprise
Minnesota
-$1.88M -87,634 Closed
RFA
57
Reilly Financial Advisors
California
-$10.6M -79,979 Closed
Alyeska Investment Group
58
Alyeska Investment Group
Illinois
-$1.61M -75,000 Closed
GCM
59
Ghisallo Capital Management
Massachusetts
-$1.07M -50,000 Closed
CSS
60
Cubist Systematic Strategies
Connecticut
-$184K -8,600 Closed
SG Americas Securities
61
SG Americas Securities
New York
-$148K -6,890 Closed
UBS Group
62
UBS Group
Switzerland
-$18K -831 Closed
PHK
63
Point72 Hong Kong
Hong Kong
-$16K -749 Closed
US Bancorp
64
US Bancorp
Minnesota
-$7K -320 Closed